Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 3/20 | 1.00 |
| ▸ | NPC1 | O15118 | 1/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.79 |
| ▸ | HPGD | P15428 | 5/20 | 0.79 |
| ▸ | GAA | P10253 | 5/20 | 0.79 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.79 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.74 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.67 |
| ▸ | LMNA | P02545 | 1/20 | 0.63 |
| ▸ | RAB9A | P51151 | 1/20 | 0.63 |
| ▸ | HIF1A | Q16665 | 10/20 | 0.60 |
| ▸ | GAPDH | P04406 | 1/20 | 0.59 |
| ▸ | MGAM | O43451 | 1/20 | 0.57 |
| ▸ | SI | P14410 | 1/20 | 0.57 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.57 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Marmesin SCHEMBL30977125 | 1.00 | ACHE (1.00) | ACHENPC1ALDH1A1HPGDGAA | |
| Marmesin SCHEMBL12062107 | 1.00 | ACHE (1.00) | ACHENPC1ALDH1A1HPGDGAA | |
| Marmesin SCHEMBL29471037 | 1.00 | ACHE (1.00) | ACHENPC1ALDH1A1HPGDGAA | |
| Marmesin SCHEMBL503874 | 0.93 | ACHE (0.86) | ACHENPC1ALDH1A1HPGDGAA | |
| Marmesin Acetate SCHEMBL2257271 | 0.85 | ALDH1A1 (1.00) | ACHENPC1ALDH1A1HPGDGAA | |
| Marmesin Acetate SCHEMBL12062110 | 0.85 | ALDH1A1 (1.00) | ACHENPC1ALDH1A1HPGDGAA | |
| Felamidin SCHEMBL30467160 | 0.81 | ALDH1A1 (0.75) | ACHENPC1ALDH1A1HPGDGAA | |
| (-)-Prantschimgin SCHEMBL13337338 | 0.81 | ALDH1A1 (0.78) | ACHENPC1ALDH1A1HPGDGAA | |
| Felamidin SCHEMBL12062114 | 0.81 | ALDH1A1 (0.75) | ACHENPC1ALDH1A1HPGDGAA | |
| SCHEMBL30777266 | 0.78 | ALDH1A1 (0.71) | ACHENPC1ALDH1A1HPGDGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 156 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4615506-A1 | USE OF GSK-3 ACTIVATIOR TO MODULATE PROTEASOME ACTIVITY TO PREVENT AGEING ASSOCIATED CONDITIONS AND DISEASES | Sahin, Fikret (TR) | 2025-09-17 | — | — | EP | claimed |
| US-20250213633-A1 | PHARMACEUTICAL COMPOSITIONS | ABDELWAHAB HISHAM HASSAN (AE) | 2025-07-03 | — | — | US | claimed |
| CN-119215104-A | Traditional Chinese medicine extract and application thereof in preparation of cell necrotic apoptosis inhibitor | 河南中医药大学 | 2024-12-31 | — | — | CN | claimed |
| WO-2024258363-A1 | USE OF GSK-3 ACTIVATIOR TO MODULATE PROTEASOME ACTIVITY TO PREVENT AGEING ASSOCIATED CONDITIONS AND DISEASES | SAHIN FIKRET (TR) | 2024-12-19 | — | — | WO | claimed |
| WO-2024134655-A1 | CITRUS PLANTS WITH MODIFIED PRODUCTION OF COUMARINS AND FURANOCOUMARINS METHODS OF PRODUCING SAME AND PRODUCTS OBTAINED THEREBY | THE STATE OF ISRAEL, MINISTRY OF AGRICULTURE & RURAL DEVELOPMENT, AGRICULTURAL RESEARCH ORGANIZATION (ARO) (VOLCANI INSTITUTE) (IL) | 2024-06-27 | — | — | WO | claimed |
| CN-116660543-A | Diagnostic and prognostic markers for nonalcoholic fatty liver disease and uses thereof | 中国人民解放军陆军军医大学第一附属医院 | 2023-08-29 | — | — | CN | claimed |
| CN-106674240-B | The isolation and purification method of alicyclic monomer in a kind of different RADIX PEUCEDANI | 成都普思生物科技股份有限公司 | 2019-03-29 | — | — | CN | claimed |
| CN-106727786-A | A kind of antipyretic of children's Integrated TCM and preparation method thereof | 郑州郑先医药科技有限公司 | 2017-05-31 | — | — | CN | claimed |
| CN-106727642-A | A kind of children's antipyretic | 郑州郑先医药科技有限公司 | 2017-05-31 | — | — | CN | claimed |
| US-20120277297-A1 | Pharmaceutical Composition Useful as Acetylcholinesterase Inhibitors | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2012-11-01 | — | — | US | claimed |
| EP-2001463-A1 | A PHARMACEUTICAL COMPOSITION USEFUL AS ACETYL CHOLINESTERASE INHIBITORS | Council of Scientific and Industrial Research (IN) | 2008-12-17 | — | — | EP | claimed |
| US-20080009544-A1 | Pharmaceutical Composition Useful as Acetylcholinesterase Inhibitors | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2008-01-10 | — | — | US | claimed |
| WO-2007107846-A1 | A PHARMACEUTICAL COMPOSITION USEFUL AS ACETYL CHOLINESTERASE INHIBITORS | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2007-09-27 | — | — | WO | claimed |
| CN-1163760-A | Health food containing active component of Tianshishan ginseng and Chinese angelica plant | DONG FAMING (CN) | 1997-11-05 | — | — | CN | claimed |
| EP-4649826-A1 | BIRD DAMAGE-PREVENTING COMPOSITION | Hanbio Co., Ltd (KR) | 2025-11-19 | — | — | EP | disclosed |
| US-20250320469-A1 | FUSION PROTEIN AND USE FOR BIOCONVERTING MOLECULES | UNIV DE LORRAINE (FR) | 2025-10-16 | — | — | US | disclosed |
| US-20250311723-A1 | METHODS AND COMPOSITIONS FOR ALTERING SECONDARY METABOLITES IN PLANTS | IMPELLO BIOSCIENCES, INC. | 2025-10-09 | — | — | US | disclosed |
| WO-2001049306-A1 | BALANITES AEGYPTIACA EXTRACTS FOR TREATMENT OF HIV/AIDS AND LEUKEMIA | HAMID OSMAN A MONIEUM (SD) | 2001-07-12 | — | — | WO | disclosed |
| CN-1163760-A | Health food containing active component of Tianshishan ginseng and Chinese angelica plant | DONG FAMING (CN) | 1997-11-05 | — | — | CN | disclosed |
| WO-1997023234-A1 | BALANITES AEGYPTIACA METHOD OF TREATMENT | NATIONAL RESEARCH COUNCIL (SD) | 1997-07-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080009544-A1 | Pharmaceutical Composition Useful as Acetylcholinesterase Inhibitors | ACHE, BCHE, CHRNB1 | ACHE 1/4885NPC1 671/4885ALDH1A1 1025/4885 |
| US-20250311723-A1 | METHODS AND COMPOSITIONS FOR ALTERING SECONDARY METABOLITES IN PLANTS | ERG28, AHCY, BROX | ACHE 2895/4885NPC1 2260/4885ALDH1A1 4108/4885 |
| US-20250320469-A1 | FUSION PROTEIN AND USE FOR BIOCONVERTING MOLECULES | BLVRB, POR, CBR3 | ACHE 3779/4885NPC1 2299/4885ALDH1A1 2325/4885 |
| US-20120277297-A1 | Pharmaceutical Composition Useful as Acetylcholinesterase Inhibitors | ACHE, BCHE, CYP3A7 | ACHE 1/4885NPC1 1194/4885ALDH1A1 547/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.